Curious about Spravato in Maryland. Learn who qualifies, how visits work, and what results to expect, with a local team ready to help.
If you live in Maryland or nearby and wonder whether Spravato can help, this guide is for you. You will learn who qualifies for Spravato in Maryland, what safety rules look like, and what results people can expect. Spravato is a nasal spray form of esketamine. It is a controlled medicine classified as CIII. Spravato is given in a clinic with careful monitoring for your safety. The Food and Drug Administration approves Spravato for adults with treatment resistant depression and for adults with major depressive disorder who have acute suicidal thoughts or behaviors. (FDA Access Data)
Table of Contents
What Spravato is and how it helps
Spravato acts on the glutamate system in the brain. This is different from many standard antidepressants. For some people, mood lifts within hours instead of weeks. Research funded by the National Institute of Mental Health shows that the pathway Spravato targets can produce rapid relief for severe depression. (National Institute of Mental Health)
Spravato now has approval in the United States for use as a single treatment for adults with treatment resistant depression. It can also be used with an oral antidepressant. For adults with major depressive disorder who have acute suicidal thoughts or behaviors, Spravato is used together with an oral antidepressant. The label notes that Spravato has not been shown to prevent suicide or reduce suicidal behavior. People may still need hospital care when that is the safest option. (FDA Access Data)
Who qualifies for Spravato in Maryland
You may qualify if any of the following is true
You are an adult with treatment resistant depression. This usually means you tried other antidepressants at the right dose and time and did not get enough relief. Your clinician will review your history in detail. Spravato can be used as one treatment on its own or together with an oral antidepressant for treatment resistant depression. (FDA Access Data)
You are an adult with major depressive disorder and have acute suicidal thoughts or behaviors. For this use, Spravato is added to an oral antidepressant and given for four weeks while your team builds a full care plan. The goal is to reduce depressive symptoms quickly. It is not a stand alone safety plan. Hospital care may still be needed if risk remains high. (FDA Access Data)
During your telehealth evaluation, we will confirm that Spravato is appropriate for you, rule out medical risks, and plan in person visits in our certified setting in Laurel Maryland. We also serve nearby communities in Alexandria Virginia and Washington DC and surrounding areas.
Safety first at every step
Spravato has important safety rules. These rules are in place to protect you and make care consistent.
What you can expect
Spravato is only given in a certified clinic under the direct supervision of trained staff. It is never dispensed for home use.
You stay for observation for at least two hours after each dose. Staff check your breathing, heart rate, blood pressure, and oxygen level. You leave only when the clinician says you are ready. You do not drive until the next day after a full night of sleep.
Common short term effects include feeling detached, dizziness, nausea, a rise in blood pressure, and sleepiness. These effects usually peak and fade the same day. Your team watches you closely and supports you through the visit. (FDA Access Data)
People with certain conditions should not receive Spravato. That includes aneurysmal vascular disease, arteriovenous malformation, or past bleeding in the brain. People with allergy to esketamine or ketamine should not receive it either. Your clinician will also review blood pressure, pregnancy plans, and other medicines to keep you safe. (FDA Access Data)
For plain language drug safety advice, you can also read the MedlinePlus page from the National Library of Medicine. It covers practical points like timing of nasal sprays used for allergies and what symptoms to report right away. (MedlinePlus)
The Spravato visit from start to finish
Here is how a visit works at Maryland Spravato and TMS Center
Check in and quick chat about how you are feeling that day.
Blood pressure and basic vital signs before dosing.
You self administer the nasal spray while a clinician guides each step.
You rest in a quiet room. Lights are low and you can listen to music if you wish.
We monitor you for at least two hours. We check for comfort, blood pressure, and oxygen level.
Before you leave, we confirm that you feel steady and have a safe ride home.
We follow up between visits and adjust the plan as needed.
If you want a step by step walkthrough, see our page Spravato What to Expect on our site. It explains the room setup, timing, and how to plan your ride home.
Spravato what to expect
Dosing schedule and timeline
For treatment resistant depression, the typical plan looks like this
Weeks 1 to 4 twice per week
Weeks 5 to 8 once per week
Week 9 and after every one to two weeks at the lowest frequency that keeps you well
Dose can be 56 milligrams or 84 milligrams based on your response and tolerability. Your clinician will decide with you. Evidence of benefit is checked after the four week start to see what comes next. (FDA Access Data)
For major depressive disorder with acute suicidal thoughts or behaviors, the plan is usually two times a week for four weeks with an oral antidepressant. After four weeks, the team decides next steps based on your progress and safety needs. (FDA Access Data)
What results look like
Many people with severe depression feel a lift in mood within one day. This rapid effect is one reason Spravato is an option when time matters. Federal research highlights how glutamate based treatments can provide fast relief for some people who did not respond to standard drugs. (National Institute of Mental Health)
At the end of the first month, we look for a clear drop in symptoms such as sadness, low energy, poor sleep, and loss of interest. If you have treatment resistant depression, maintenance visits may keep the gains going. Your plan is personalized to the lowest number of visits that hold your progress. The Food and Drug Administration label explains this schedule and the review at four weeks. (FDA Access Data)
If you have major depressive disorder with acute suicidal thoughts or behaviors, the goal is fast reduction in depressive symptoms while the team strengthens your safety plan. The label states that Spravato has not been proven to prevent suicide or reduce suicidal behavior and hospital care may still be needed. We take that guidance seriously and always put safety first. (FDA Access Data)
Who should prepare for extra review
Tell your clinician if any of the following applies to you
Uncontrolled high blood pressure or heart disease
Past stroke or any brain blood vessel problem
Pregnancy or plans for pregnancy or breastfeeding
History of substance use concerns
Current use of medicines that can slow breathing or make you very sleepy
These reviews help us tailor your plan. The official label lists the key warnings. We follow those rules in our clinic. (FDA Access Data)
Why choose Maryland Spravato and TMS Center
In person Spravato treatment in a certified setting in Laurel Maryland
Telehealth evaluation for convenience and speed
Care for people across Maryland, Washington DC, and Northern Virginia including Alexandria
A calm space and a skilled team that guides you through every visit
Options to combine Spravato with talk therapy, medication management, and TMS when helpful
Learn more about Spravato and how it works on our overview page: Spravato Esketamine
Quick tips for a smooth first visit
Plan a ride to and from the clinic. You will not drive the day of dosing. (FDA Access Data)
Eat a light snack a few hours before and avoid large meals. Nausea is less likely when the stomach is not full. (FDA Access Data)
Bring music or a mindfulness exercise you enjoy.
Set one clear goal for the visit such as better sleep or more energy.
Dress in comfy layers and arrive a few minutes early.
The bottom line on Spravato in Maryland
Spravato in Maryland is a monitored, clinic based option for adults with treatment resistant depression and for adults with major depressive disorder who have acute suicidal thoughts or behaviors. It can work fast, it follows strict safety rules, and it fits into a full plan that supports your long term health. If you live in Laurel, the DC area, or Northern Virginia, our team can start with a telehealth evaluation and build an in person plan that fits your life.
References you can trust
For full details on uses, dosing, and safety, see the Food and Drug Administration label for Spravato and the overview of the REMS program. For plain language guidance, see MedlinePlus. For research background on rapid relief and glutamate based treatments, see the National Institute of Mental Health updates. (FDA Access Data)
